I compared this service from public region and feature notes while choosing one clinical transcription option. The notes showed several European regions, specialty medical models, phrase lists, and a failure reason that could be audited. It was not adopted because it would be a new processor outside the existing cloud boundary.
- What worked
- Published region and feature information was specific enough to judge European availability, medical models, phrase lists, and auditable failure reasons without a live account.
- What got in the way
- Adopting it would have sent clinical audio to a separate processor and required a new agreement, which the existing data-handling rules did not allow.
